Target intelligence / Profile preview

D-alanyl-D-alanine motif on peptidoglycan precursor

Molecular classification
Other (structural motif on bacterial cell wall precursors)
01

Overview

The D-alanyl-D-alanine motif is a dipeptide structure present at the terminal position of the peptide side chain in peptidoglycan precursors of most Gram-positive and Gram-negative bacteria[1][3][5][6]. This motif is generated in the cytoplasm through the action of D-alanine racemase and D-alanine-D-alanine ligase, with the terminal D-Ala-D-Ala forming a critical recognition sequence for enzymes involved in peptidoglycan polymerization and cross-linking during cell wall biosynthesis[5][6]. It serves as the direct binding site for glycopeptide antibiotics such as vancomycin, which anchor to this motif and thereby block cell wall assembly, causing bactericidal effects[1][2][6]. Resistance can arise when bacteria alter the terminal motif to D-Ala-D-Lac or D-Ala-D-Ser, markedly reducing antibiotic affinity and causing clinical treatment failure[1][2]. This motif is a central node for antibiotic mechanism-of-action and resistance pathways, as well as a defining feature for bacterial viability and pathogenicity.

Other names
D-Ala-D-Ala motifD-alanyl-D-alanine dipeptideD-alanyl-D-alanine terminusD-Ala-D-Ala end
02

Mechanism of action

Vancomycin and related glycopeptides bind to the D-alanyl-D-alanine motif, forming a stable non-covalent complex that sterically blocks transglycosylase and transpeptidase enzymes, inhibiting cross-linking and elongation of peptidoglycan, leading to cell lysis[1][2][6]. D-cycloserine inhibits precursor synthesis by inhibiting D-alanine racemase and D-Ala-D-Ala ligase, preventing formation of the D-Ala-D-Ala motif[5][7]. β-lactam antibiotics (e.g., penicillins) competitively inhibit transpeptidases by mimicking the D-Ala-D-Ala structure, preventing cross-linking of peptidoglycan[6].

03

Biological functions

Cell wall biosynthesisMaintenance of bacterial cell shape and structural integrityRegulation of osmotic pressure in bacteria
04

Disease associations

InfectionAntimicrobial resistance
05

Safety considerations

Emergence of resistance: Bacteria expressing altered motifs (D-Ala-D-Lac or D-Ala-D-Ser) reduce glycopeptide antibiotic binding, leading to high-level vancomycin resistance[1][2].No direct human safety concerns since this motif is unique to bacteria, not present in human cells[6].
06

Interacting drugs

Vancomycin

3 more in the full profile.

07

Biomarkers

Presence or modification of D-Ala-D-Ala on peptidoglycan precursors can be a marker for vancomycin susceptibility/resistance in bacteria[2].

Beyond the preview

Go deeper on D-alanyl-D-alanine motif on peptidoglycan precursor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-alanyl-D-alanine motif on peptidoglycan precursor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call